Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Inorg Chem ; 49(11): 4753-5, 2010 Jun 07.
Artigo em Inglês | MEDLINE | ID: mdl-20438094

RESUMO

Treatment of tris(3-cyano-2,4-pentanedionato)manganese(III) with KTp*, followed by [NEt(4)]CN affords [NEt(4)][(Tp*)Mn(III)(CN)(3)] (1); subsequent treatment of 1 with divalent triflates (OTf) and 2,2'-bipyridine (bpy) affords {Mn(III)(2)M(II)(2)} complexes (M(II) = Mn, 2; Ni, 3). Magnetic measurements show that 1-3 exhibit S(T) = 1, 3, and 4 spin ground states, respectively.

2.
Ann Surg ; 238(2): 235-40, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12894017

RESUMO

OBJECTIVE: To evaluate the impact of spleen weight on operative and clinical outcome in a series of 108 consecutive laparoscopic splenectomies. BACKGROUND: Laparoscopic splenectomy as an alternative to open splenectomy for splenomegaly is regarded as controversial. METHODS: Patients underwent laparoscopic splenectomy for a range of hematological disorders between November 1992 and February 2000. Multiple linear and logistic regression analysis were used to assess the effect of massive splenomegaly (>1000 g) on perioperative mortality and morbidity, after adjusting for the joint effects of patient age, weight, pre- and postoperative full blood counts, operating time, estimated blood loss, conversion rate, reoperation rate, and duration of hospital stay. RESULTS: Massive splenomegaly was recorded in 27 of 108 (25%) cases. In this group, splenic weight ranged from 1000 to 4750 g (median, 2500 g). Patients with splenic weight >1000 g had a significantly longer median operating time (170 vs. 102 minutes, P < 0.01), conversion rate (5/27 vs. 4/81, P < 0.05), postoperative morbidity (15/27 vs. 4/81, P < 0.01), and median postoperative stay (5 vs. 3 days, P < 0.01). Multivariate analysis found splenic weight to be the most powerful predictor of morbidity (P < 0.01). Patients with splenomegaly (>1000 g) were 14 times likely to have post operative complications. One patient died 3 days after surgery, following a pulmonary embolus (spleen weight 500 g, mortality 1/108, 0.9%). CONCLUSIONS: Laparoscopic splenectomy is feasible in patients with giant spleens. However, it is associated with greater morbidity, and the advantages of minimal access surgery in this subgroup of patients are not so clear.


Assuntos
Laparoscopia/efeitos adversos , Esplenectomia/efeitos adversos , Esplenomegalia/cirurgia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Feminino , Seguimentos , Doenças Hematológicas/cirurgia , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Reoperação , Estudos Retrospectivos , Esplenectomia/métodos , Esplenomegalia/patologia , Estatísticas não Paramétricas , Reino Unido/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA